Quick Takeaways
- Avidity Partners Management LP filed SCHEDULE 13G/A for Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value (SYRS).
- Disclosed ownership: 7.6%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"Avidity Partners Management LP disclosed 7.6% ownership in Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value (SYRS) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Avidity Partners Management LP | 7.6% | 2,048,020 | 0 | 2,048,020 | By Avidity Partners Management (GP) LLC, its general partner, By: /s/ Michael Gregory | Michael Gregory/Managing Member | |
| Avidity Partners Management (GP) LLC | 7.6% | 2,048,020 | 0 | 2,048,020 | By: /s/ Michael Gregory | Michael Gregory/Managing Member | |
| Avidity Capital Partners Fund (GP) LP | 7.6% | 2,048,020 | 0 | 2,048,020 | By Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory | Michael Gregory/Managing Member | |
| Avidity Capital Partners (GP) LLC | 7.6% | 2,048,020 | 0 | 2,048,020 | By: /s/ Michael Gregory | Michael Gregory/Managing Member | |
| Avidity Master Fund LP | 2.9% | 781,970 | 0 | 781,970 | By Avidity Capital Partners Fund (GP) LP, its general partner, By: Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory | Michael Gregory/Managing Member | |
| Avidity Private Master Fund I LP | 4.4% | 1,169,610 | 0 | 1,169,610 | By Avidity Capital Partners Fund (GP) LP, its general partner, By: Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory | Michael Gregory/Managing Member | |
| David Witzke | 0% | 0 | 0 | 0 | By: /s/ David Witzke | David Witzke | |
| Michael Gregory | 7.6% | 2,048,020 | 0 | 2,048,020 | By: /s/ Michael Gregory | Michael Gregory |